Epstein-Barr Virus (EBV), DNA Probe
Code:18044|CPT:88365|LOINC:5004-7
| Includes | EBV, DNA Probe |
|---|
Analysis details
Methodology
- In situ hybridization
- Real-time polymerase chain reaction (RT-PCR)
Expected Turnaround Time
1–2 days
Special Instructions
—
How to use
The Epstein-Barr Virus (EBV), DNA Probe test detects EBV DNA in clinical material by real-time PCR and localizes EBV-encoded nucleic acids in tissue sections by in situ hybridization as an adjunct to histopathology. These complementary approaches are used to establish EBV infection and to evaluate EBV-related pathology. Clinical applications include diagnosis of infectious mononucleosis, assistance with distinguishing EBV from other herpesvirus infections and from exudative tonsillopharyngitis of alternative etiologies, and detection of EBV reactivation in immunocompromised and transplant recipients. Synonyms used in practice include EBV DNA testing and EBV in situ hybridization.
Limitations
Epstein-Barr virus is a ubiquitous human herpesvirus that replicates predominantly in B lymphocytes and can also infect T lymphocytes and epithelial cells. Transmission typically occurs via respiratory secretions. Primary infection often arises in childhood and is asymptomatic or mild, whereas adolescents and adults more commonly present with infectious mononucleosis characterized by fever, lymphadenopathy, tonsillopharyngitis, and hepatosplenomegaly. Reported complications include hepatitis, pneumonia, hemolytic anemia, thrombocytopenia, aplastic anemia, splenic rupture, myocarditis, and neurologic disease such as Guillain–Barré syndrome, encephalitis, and meningitis. In rare cases, chronic active EBV persists beyond six months with organ involvement and high EBV-specific antibody titers. Following primary infection, EBV establishes lifelong latency in memory B cells and may reactivate with immunodeficiency or iatrogenic immunosuppression, contributing to lymphoproliferative disorders and nasopharyngeal carcinoma. Nucleic acid–based detection employs in situ hybridization to visualize EBV-encoded sequences in tissue or PCR to amplify EBV genomic targets from clinical specimens. Failure to identify target DNA can reflect improper sampling, handling, or fixative, or target copy number below the assay’s analytical sensitivity.
| Unit | qualitative |
|---|---|
| Reference interval | — |
| Indications | Early workup of suspected infectious mononucleosis with hepatosplenomegaly, tonsillopharyngitis, cervical or submandibular lymphadenopathy, or atypical lymphocytosis, prior to seroconversion, Evaluation of individuals with HIV infection when EBV infection or reactivation is a concern, Assessment of transplant recipients on immunosuppression with suspected EBV reactivation |
Possible Causes of Abnormal Results
Decreased levels
- antiviral therapy
- improper fixation
- improper handling
- improper sampling
- low target DNA concentration
Specimen Requirements
| Specimen | Unspecified specimen |
|---|---|
| Container | Per Test Requirement |
| Storage Instructions | Room temperature |
References
Berg LC, Copenhaver CM, Morrison VA, et al. B-cell lymphoproliferative disorders in solid-organ transplant patients: Detection of Epstein-Barr virus by in situ hybridization. Hum Pathol. 1992;23(2):159-163. PubMed 1310951
De Souza YG, Freese UK, Greenspan D, Greenspan JS. Diagnosis of Epstein-Barr virus infection in hairy leukoplakia by using nucleic acid hybridization and noninvasive techniques. J Clin Microbiol. 1990;28(12):2775-2778. PubMed 2177752
Hamilton-Dutoit SJ, Delecluse HJ, Raphael M, Lenoir G, Pallesen G. Detection of Epstein-Barr virus genomes in AIDS related lymphomas: sensitivity and specificity of in situ hybridisation compared with Southern blotting. J Clin Pathol. 1991;44(8):676-680. PubMed 1653789
Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481-492.
Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004;42(8):3381-3387.
Исаков В.А., Борисова В.В., Исаков Д.В. Герпес: патогенез и лабораторная диагностика: руководство для врачей. СПб: Лань; 1999. 192 с.
Johannsen EC, Schooley RT, Kaye KM. Epstein-Barr Virus (Infectious Mononucleosis). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Churchill Livingstone; 2005.
Tselis A, Jenson HB. Epstein-Barr Virus. New York, NY: Taylor & Francis; 2006.